Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty: A Randomized Double-Blind Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorPoznan University of Medical Sciences

About this trial

his study will test whether giving dexamethasone through a vein can improve pain control after total hip replacement surgery. Dexamethasone is commonly used to reduce nausea and may also help with pain, but it is not clear which dose works best. Patients will be randomly assigned to receive either no dexamethasone, 4 mg, or 8 mg, in addition to standard anesthesia and a nerve block (PENG block). The main goal is to see how long patients go without needing additional pain medication after surgery. The study will also look at pain levels, use of opioid painkillers, nausea and vomiting, blood sugar levels, and possible side effects.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Scheduled for elective total hip arthroplasty (THA)

Planned use of regional anesthesia including PENG block

American Society of Anesthesiologists (ASA) physical status I-III

Disqualifiers

Known hypersensitivity to dexamethasone or any component of the study medication

Chronic corticosteroid therapy or use of systemic steroids within 14 days prior to surgery

Active systemic infection or sepsis

Significant immunosuppression (e.g., chemotherapy, biological therapy)

Trial design

Treatments tested in this trial

  • Dexamethasone 4mg
  • Placebo
  • Dexamethasone 8mg

Treatment groups

198 Participants
are divided into 3 treatment groups